Francesco J. Romano - Publications

Correction: Maione et al. Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option? Curr. Oncol. 2026, 33, 54.

Journal: Current oncology (Toronto, Ont.)

Published: June 25, 2026

Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option?

Journal: Current oncology (Toronto, Ont.)

Published: December 01, 2025

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.

Journal: Frontiers in oncology

Published: October 13, 2025

From Transcription Factors Dysregulation to Malignancy: In Silico Reconstruction of Cancer's Foundational Drivers-The Eternity Triangle.

Journal: International journal of molecular sciences

Published: August 10, 2025

The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 08, 2024

Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

Published: April 02, 2023

Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results.

Journal: Clinical lung cancer

Published: January 21, 2023

Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.

Journal: Cancer diagnosis & prognosis

Published: October 10, 2022

Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerations.

Journal: American journal of otolaryngology

Published: December 14, 2020

Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study.

Journal: Oncotarget

Published: September 28, 2020

Water-soluble silicon nanocrystals as NIR luminescent probes for time-gated biomedical imaging.

Journal: Nanoscale

Published: April 02, 2020

Amine functionalised silicon nanocrystals with bright red and long-lived emission.

Journal: Faraday discussions

Published: February 27, 2020